Cancer Genomics and Biomarkers in Pediatrics: Shaping the Future of Pediatric Oncology
The integration of cancer genomics and biomarkers into pediatric oncology has revolutionized how we understand, diagnose, and treat pediatric cancers. With advances in technology and precision medicine, we now have the ability to target treatments more effectively and identify high-risk patients early. This session will highlight the key role genomics and biomarkers play in transforming pediatric cancer care.
Key Focus Areas:
- Genomic Landscape of Pediatric Cancer
- Role of Biomarkers in Early Diagnosis
- Precision Medicine in Pediatric Oncology
- Innovative Therapies and Targeted Drugs
- Biomarkers for Prognosis and Treatment Response
- Genomic Data and Clinical Trials
Related Conference of Cancer Genomics and Biomarkers in Pediatrics: Shaping the Future of Pediatric Oncology
June 29-30, 2026
35th International Conference on Pediatrics, Neonatology and Pediatric Nursing
Barcelona, Spain
July 06-07, 2026
10th Annual World Congress on Pediatric Nutrition, Gastroenterology and Child Development
Barcelona, Spain
August 10-11, 2026
42nd International Conference on Pediatric and Nutritional Research
Toronto, Canada
August 24-25, 2026
12th International Conference on Pediatrics Research and Adolescent Medicine
London, UK
September 17-18, 2026
8th International Conference on Pediatrics, Neonatology and Healthcare
London, UK
October 19-20, 2026
18th World Congress on Pediatrics, Neonatology and Pediatric Surgery
Paris, France
November 12-13, 2026
7th International Conference on Pediatrics, Child Health and Emergency Care
Barcelona, Spain
February 18-19, 2027
24th International Conference on Pediatrics and Pediatric Cardiology
Paris, France
March 22-23, 2027
10th International Pediatrics, Infectious Diseases and Healthcare Conference
Singapore City, Singapore